We are live on ! Find out more
NPTN

NEOPHOTONICS CORP

Delisted

NPTN was delisted on the 2nd of August, 2022.

132 hedge funds and large institutions have $427M invested in NEOPHOTONICS CORP in 2016 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 36 increasing their positions, 42 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

213% more call options, than puts

Call options by funds: $1.07M | Put options by funds: $341K

100% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 20

44% more capital invested

Capital invested by funds: $296M → $427M (+$130M)

18% more funds holding

Funds holding: 112132 (+20)

14% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 42

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

Holders
132
Holders Change
+20
Holders Change %
+17.86%
% of All Funds
3.52%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.11%
New
40
Increased
36
Reduced
42
Closed
20
Calls
$1.07M
Puts
$341K
Net Calls
+$727K
Net Calls Change
+$782K
Name Holding Trade Value Shares
Change
Change in
Stake
TRCT
151
Tower Research Capital (TRC)
New York
-$11K -1,000 Closed
BJ
152
BlackRock Japan
Japan
-$3K -298 Closed

NPTN Hedge Fund Activity: Q1 2016 in Review

132 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in NEOPHOTONICS CORP (NPTN) for Q1 2016, worth a combined $427M — up 44% from $296M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new NPTN positions and 20 closed out — a net gain of 20 holders — while 36 added to existing stakes and 42 trimmed.

The largest buyer was Glenmede Trust, opening a new position worth an estimated $14.4M. The largest seller was Royce & Associates, cutting an estimated $9.26M.

  • 132 institutional investors held NEOPHOTONICS CORP (NPTN) as of Q1 2016, up from 112 in Q4 2015.
  • Funds reported $427M of NEOPHOTONICS CORP stock for Q1 2016, up 44% quarter-over-quarter.
  • 40 funds opened new NEOPHOTONICS CORP positions in Q1 2016 and 20 closed out, a net change of +20 holders.
  • The largest NEOPHOTONICS CORP buyer in Q1 2016 was Glenmede Trust, an estimated $14.4M added.
  • The largest NEOPHOTONICS CORP seller in Q1 2016 was Royce & Associates, an estimated $9.26M sold.

Based on aggregated 13F filings for Q1 2016.